Effect Of The Consumption Of Fermented Dairy Drink On Common Infections In Shift-Workers

NCT ID: NCT00753961

Last Updated: 2017-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1340 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical study plans to investigate the effect of the consumption of a fermented dairy drink on the occurrence of common infections. This study will be performed in a healthy adult population of shift workers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

fermented dairy product

Group Type ACTIVE_COMPARATOR

fermented dairy product

Intervention Type OTHER

fermented dairy product (2 bottles/day during 16 weeks)

2

non fermented acidified dairy product.

Group Type PLACEBO_COMPARATOR

non fermented dairy product

Intervention Type OTHER

non fermented dairy product (2 bottles/day during 16 weeks)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fermented dairy product

fermented dairy product (2 bottles/day during 16 weeks)

Intervention Type OTHER

non fermented dairy product

non fermented dairy product (2 bottles/day during 16 weeks)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male/female subjects aged 18 to 65 years (bounds included)
* Healthy subjects.
* Subjects working in two- or three-shift work including night work

Exclusion Criteria

* Subject with any food allergy
* Subject in a situation that, in the investigator opinion, could interfere with optimal participation in the present study or could constitute a special risk for the subject.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Danone Global Research & Innovation Center

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SGS

Antwerp, , Belgium

Site Status

Therapharm

Caen, , France

Site Status

Hospital de la Santa Creu

Barcelona, , Spain

Site Status

VEEDA

Plymouth, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium France Spain United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NU289

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Survival Plant-Based
NCT06768229 COMPLETED NA
Symbiotic & Colonization
NCT01983072 COMPLETED PHASE2